Učitavanje...
Lymphocyte-Activation Gene 3 (LAG3): the Next Immune Checkpoint Receptor
Immune checkpoint therapy has revolutionized cancer treatment by blocking inhibitory pathways in T cells that limits the an effective anti-tumor immune response. Therapeutics targeting CTLA-4 and PD1/PDL1 have progressed to first line therapy in multiple tumor types with some patients exhibiting tum...
Spremljeno u:
| Izdano u: | Semin Immunol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920665/ https://ncbi.nlm.nih.gov/pubmed/31604537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2019.101305 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|